Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Neoplasms 37 Depression 29 Prostatic Neoplasms 23 Fatigue 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 13 Carcinoma, Non-Small-Cell Lung 13 Anxiety Disorders 13 Lymphoma, Mantle-Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Pain 11 Lymphoma, Non-Hodgkin 11 Lymphoma, B-Cell, Marginal Zone 11 Lung Neoplasms 11 Lymphoma, Large-Cell, Immunoblastic 10 Leukemia, Myeloid, Acute 10 Colorectal Neoplasms 10 Leukemia, Myeloid, Chronic-Phase 9 Hodgkin Disease 9 Blast Crisis 9 Vomiting 8 Nausea 8 Lymphoma 8 Leukemia, Myeloid, Accelerated Phase 8 Head and Neck Neoplasms 8 Uterine Cervical Neoplasms 7

Interventions

HhAntag691 21 Biopsy 11 Imiquimod 10 Aminolevulinic Acid 9 sonidegib 8 Photochemotherapy 8 Nivolumab 8 1-phenyl-3,3-dimethyltriazene 7 methyl 5-aminolevulinate 6 cemiplimab 6 Surgical Procedures, Operative 5 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Mohs Surgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Tomography, Optical Coherence 3 Standard of Care 3 Niacinamide 3 Microscopy, Confocal 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Basal Cell × Therapeutics × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡